We are live on ! Find out more
NXTM

NxStage Medical Inc.
NXTM

Delisted

NXTM was delisted on the 21st of February, 2019.

Back to rankings

1 hedge funds and large institutions have $112M invested in NxStage Medical Inc. in 2019 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 171 closing their positions.

New
Increased
Maintained
Reduced
Closed

91% less funds holding in top 10

Funds holding in top 10: 11 → 1 (-10)

93% less capital invested

Capital invested by funds: $1.73B → $112M (-$1.62B)

99% less funds holding

Funds holding: 172 → 1 (-171)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 171

Holders
1
Holders Change
-171
Holders Change %
-99.42%
% of All Funds
0.02%
Holding in Top 10
1
Holding in Top 10 Change
-10
Holding in Top 10 Change %
-90.91%
% of All Funds
0.02%
New
–
Increased
–
Reduced
–
Closed
171
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$176M
2
BlackRock
BlackRock
New York
-$155M
3
AA
AQR Arbitrage
Connecticut
-$105M
4
MF
Magnetar Financial
Illinois
-$84.9M
5
AAM
Alpine Associates Management
Florida
-$69.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
KLCMU
26
Kite Lake Capital Management (UK)
United Kingdom
– -$18.8M -655,364 Closed
TA
27
Tamarack Advisers
California
– -$17.9M -625,000 Closed
Bank of New York Mellon
28
Bank of New York Mellon
New York
– -$15.1M -526,655 Closed
LP
29
LMR Partners
United Kingdom
– -$14.6M -509,486 Closed
Morgan Stanley
30
Morgan Stanley
New York
– -$12.7M -445,036 Closed
Canada Pension Plan Investment Board
31
Canada Pension Plan Investment Board
Ontario, Canada
– -$12.3M -428,300 Closed
Bank of Montreal
32
Bank of Montreal
Ontario, Canada
– -$12.1M -423,596 Closed
GCIA
33
Gabelli & Co Investment Advisers
New York
– -$11.9M -417,045 Closed
Man Group
34
Man Group
United Kingdom
– -$11.8M -411,843 Closed
Allianz Asset Management
35
Allianz Asset Management
Germany
– -$11.6M -404,771 Closed
Charles Schwab
36
Charles Schwab
California
– -$10.4M -363,568 Closed
Deutsche Bank
37
Deutsche Bank
Germany
– -$10.3M -359,501 Closed
PCM
38
Pentwater Capital Management
Florida
– -$10.2M -355,000 Closed
Renaissance Technologies
39
Renaissance Technologies
New York
– -$9.52M -332,783 Closed
DCM
40
DAFNA Capital Management
California
– -$8.93M -312,119 Closed
GF
41
Gabelli Funds
New York
– -$8.87M -310,029 Closed
WIC
42
Water Island Capital
New York
– -$8.44M -294,790 Closed
FBCM
43
Fort Baker Capital Management
California
– -$7.96M -278,178 Closed
AGM
44
Alpine Global Management
New York
– -$7.16M -250,000 Closed
Grantham, Mayo, Van Otterloo & Co (GMO)
45
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
– -$6.64M -232,100 Closed
AllianceBernstein
46
AllianceBernstein
Tennessee
– -$6.58M -229,846 Closed
Wells Fargo
47
Wells Fargo
California
– -$6.5M -227,019 Closed
TI
48
TT International
United Kingdom
– -$6.31M -220,402 Closed
LOAMU
49
Lombard Odier Asset Management (USA)
New York
– -$6.3M -220,000 Closed
State of Wisconsin Investment Board
50
State of Wisconsin Investment Board
Wisconsin
– -$6.14M -214,381 Closed
1
2
3 4 5

NXTM Hedge Fund Activity: Q1 2019 in Review

1 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q1 2019, worth a combined $112M — down 93% from $1.73B a quarter earlier.

Sellers outnumbered buyers: 171 funds closed out of NXTM and 0 opened new positions — a net loss of 171 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $176M sold.

  • 1 institutional investor held NxStage Medical Inc. (NXTM) as of Q1 2019, down from 172 in Q4 2018.
  • Funds reported $112M of NxStage Medical Inc. stock for Q1 2019, down 93% quarter-over-quarter.
  • 0 funds opened new NxStage Medical Inc. positions in Q1 2019 and 171 closed out, a net change of -171 holders.
  • The largest NxStage Medical Inc. seller in Q1 2019 was Vanguard Group, an estimated $176M sold.

Based on aggregated 13F filings for Q1 2019.